| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c8d4dc7bd1a30d8fda907fceaeb4e69 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-22 |
| filingDate |
1995-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bd7f6c6c7971d1e8ec78cede5580e0d |
| publicationDate |
1997-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H0952831-A |
| titleOfInvention |
Acute renal failure treatment / prevention agent |
| abstract |
(57) [Summary] [Solution] 3-Methyl-1-phenyl-2-pyrazoline-5- A prophylactic / therapeutic agent for acute renal failure (for example, warm ischemic acute renal failure) containing ON or a physiologically acceptable salt thereof as an active ingredient. [Effect] It is useful for the prevention and / or treatment of warm ischemic acute renal failure, which is caused when the blood flow is temporarily lowered under physiological temperature. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7312239-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6933310-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006126625-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012509339-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8076368-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010087306-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014139195-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9006280-B2 |
| priorityDate |
1995-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |